trials

(Bloomberg) -- AbbVie Inc. shares fell. (ABBV) fell by the most in three years after two mid-stage trials of its schizophrenia drug failed to meet their primary target, a blow to the company's $8.7 billion acquisition of Cerevel…

Yesterday, the Ministry of Defense conducted experiments in southern Israel in which Israeli startups and veteran defense companies demonstrated technologies and systems for intercepting drones. The trials were held…

By Ludwig Berger (Reuters) - Sanofi Nasdaq:NASDAQ:NASDAQ:MSN’S most advanced multiple sclerosis drug failed to meet the main goal of two late-stage trials to treat recurrent forms of the disease, dimming the prospects for a broad…

Russia is reportedly set to begin experiments on cryptocurrency exchanges and token transactions for cross-border payments to mitigate the impact of international sanctions. Russia appears to be days away from starting trials of…

(Reuters) - Boeing Co has begun flight tests of its long-awaited 777-9 jetliner with U.S. aviation regulators on board, the U.S. planemaker said in an emailed statement. The company said it made its first flight on Friday evening after…

Hong Kong, the dynamic hub of Asian finance, has taken a pioneering leap into the future of digital currency. in This is the first step of its kindChina has launched a pilot program for its electronic currency CNY, or digital yuan,…

BioAtla, a biotechnology company, has announced its first-quarter financial results and provided a business update, highlighting positive data from ongoing clinical trials and the potential for strategic partnerships. The company showcased…

Gritstone bio (GRTS) has unveiled promising preliminary data from its GRANITE personalized cancer vaccine program during its First Quarter 2024 Earnings Call. The clinical updates showed a positive trend in progression-free survival (PFS)…

BOSTON and ATLANTA - Inhibikase Therapeutics, Inc. (NASDAQ:IKT), a pharmaceutical company engaged in developing treatments for Parkinson's disease and related disorders, has announced significant advancements in its clinical trials,…

Ocean Harvesting Technologies AB, the developer of the wave energy converter InfinityWEC, is raising 500,000 Euro to fund a design update of its technology and prepare for upcoming sea trials.Since 2017, Ocean Harvesting has been…